1. Home
  2. DNN vs IDYA Comparison

DNN vs IDYA Comparison

Compare DNN & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Denison Mines Corp (Canada)

DNN

Denison Mines Corp (Canada)

HOLD

Current Price

$3.18

Market Cap

3.4B

ML Signal

HOLD

Logo IDEAYA Biosciences Inc.

IDYA

IDEAYA Biosciences Inc.

HOLD

Current Price

$29.53

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DNN
IDYA
Founded
1954
2015
Country
Canada
United States
Employees
N/A
N/A
Industry
Other Metals and Minerals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
2.9B
IPO Year
1998
2019

Fundamental Metrics

Financial Performance
Metric
DNN
IDYA
Price
$3.18
$29.53
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
16
Target Price
$6.50
$52.86
AVG Volume (30 Days)
21.5M
780.3K
Earning Date
05-12-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
61.90
EPS
N/A
N/A
Revenue
N/A
$218,710,000.00
Revenue This Year
$403.36
N/A
Revenue Next Year
N/A
$201.05
P/E Ratio
N/A
N/A
Revenue Growth
N/A
3024.43
52 Week Low
$1.51
$18.26
52 Week High
$4.43
$39.28

Technical Indicators

Market Signals
Indicator
DNN
IDYA
Relative Strength Index (RSI) 34.71 49.97
Support Level $2.56 $29.51
Resistance Level $3.36 $31.07
Average True Range (ATR) 0.19 1.12
MACD -0.07 0.22
Stochastic Oscillator 9.55 84.69

Price Performance

Historical Comparison
DNN
IDYA

About DNN Denison Mines Corp (Canada)

Denison Mines Corp is engaged in uranium mining-related activities, including the acquisition, exploration, development, and mining of uranium-bearing properties, as well as the processing, sale, and investment in uranium. The company's key properties include Wheeler River, Waterbury Lake, McClean Lake, Midwest, and others. It operates through two segments: the Mining segment and the Corporate and Other segment. The majority of the company's revenue is generated from the Mining segment, which includes activities related to exploration, evaluation, and development, mining, milling (including toll milling), and the sale of mineral concentrates.

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275 (Werner Helicase), IDE161 (PARG), and IDE705 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

Share on Social Networks: